Mineralys Therapeutics, Inc. MLYS
- lorundrostat — Hypertension NDA Submitted
- lorundrostat — Chronic Kidney Disease Phase 2
- lorundrostat — Obstructive Sleep Apnea Phase 2
Home › Targets › aldosterone synthase
Companies with an active program directed at aldosterone synthase.